Basilea Pharmaceutica AG
BPMUF
$77.40
$11.9018.17%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.15% | 14.34% | 0.13% | 59.47% | 8.98% |
| Total Depreciation and Amortization | -1.15% | -64.97% | 0.13% | 203.20% | 8.97% |
| Total Amortization of Deferred Charges | -1.15% | 58.90% | 0.13% | -65.60% | 8.94% |
| Total Other Non-Cash Items | -1.15% | 199.86% | 0.14% | -64.66% | 8.98% |
| Change in Net Operating Assets | 1.15% | -279.90% | 0.13% | 1,658.61% | -8.98% |
| Cash from Operations | -1.15% | -51.40% | 0.13% | 74.58% | 8.98% |
| Capital Expenditure | 1.13% | 82.21% | -0.13% | -638.44% | -9.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.89% | 75.88% | -0.21% | -65.07% | -9.09% |
| Cash from Investing | 1.15% | 81.82% | -0.13% | -509.84% | -8.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 108.11% | 0.00% | -63.51% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 26.33% | 0.00% | 52.33% | 0.00% |
| Cash from Financing | 1.15% | 29.92% | -0.13% | 50.44% | -8.98% |
| Foreign Exchange rate Adjustments | 1.45% | 26.60% | 0.00% | -40.30% | -9.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.15% | -53.94% | 0.13% | 274.21% | 8.98% |